Ziel/ Aim Alpha-particle emitters display high linear energy transfer combined with short range and are promising for treatment of tumor micrometastases. Indeed, efficiency and high specificity of tumor-specific antibodies labeled with alpha emitting nuclides were described in vitro and in vivo. Radiolabeled somatostatin analogues with high affinity to somatostatin receptor overexpressing tumors are an attractive option for peptide-receptor radionuclide therapy of metastasized neuroendocrine tumors. In this study, we investigated cellular effects of alpha-particle emitter Ac-225 labeled somatostatin analogue DOTATOC in vitro. Cellular studies were performed in p53 dependent and somatostatin receptor expressing rat pancreatic acinar carcino...
The overexpression of cholecystokinin B receptor (CCKBR) in human cancers led to the development of ...
In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in...
IMPORTANCE Targeted alpha therapy attempts to deliver systemic radiation selectively to cancer cells...
Rationale Key biologic effects of the alpha-particle emitter Actinium-225 in comparison to the beta-...
Peptide receptor radionuclide therapy (PRRT) using somatostatin analogues labeled with beta-particle...
were studied to evaluate the significance of γH2AX-foci formation. cytotoxicity. values of 10 MBq/m...
International audienceThe widespread use of peptide receptor radionuclide therapy (PRRT) represents ...
Targeted alpha therapy (TAT) is promising for improvement of current peptide receptor radionuclide ...
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy which may be...
Alpha-particle emitter radiopharmaceutical therapy (alpha-RPT) is a promising approach to cancer the...
Cancer being one of the leading causes of death globally, raises an international fight to defeat an...
Alpha-particles are suitable to treat cancer micrometastases because of their short range and very h...
Background Targeted alpha therapy has been postulated to have great potential for the treatment of s...
Neuroendocrine tumors express somatostatin receptors at the cell surface. In molecular imaging, this...
International audienceIdentified in 1973, somatostatin (SST) is a cyclic hormone peptide with a shor...
The overexpression of cholecystokinin B receptor (CCKBR) in human cancers led to the development of ...
In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in...
IMPORTANCE Targeted alpha therapy attempts to deliver systemic radiation selectively to cancer cells...
Rationale Key biologic effects of the alpha-particle emitter Actinium-225 in comparison to the beta-...
Peptide receptor radionuclide therapy (PRRT) using somatostatin analogues labeled with beta-particle...
were studied to evaluate the significance of γH2AX-foci formation. cytotoxicity. values of 10 MBq/m...
International audienceThe widespread use of peptide receptor radionuclide therapy (PRRT) represents ...
Targeted alpha therapy (TAT) is promising for improvement of current peptide receptor radionuclide ...
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy which may be...
Alpha-particle emitter radiopharmaceutical therapy (alpha-RPT) is a promising approach to cancer the...
Cancer being one of the leading causes of death globally, raises an international fight to defeat an...
Alpha-particles are suitable to treat cancer micrometastases because of their short range and very h...
Background Targeted alpha therapy has been postulated to have great potential for the treatment of s...
Neuroendocrine tumors express somatostatin receptors at the cell surface. In molecular imaging, this...
International audienceIdentified in 1973, somatostatin (SST) is a cyclic hormone peptide with a shor...
The overexpression of cholecystokinin B receptor (CCKBR) in human cancers led to the development of ...
In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in...
IMPORTANCE Targeted alpha therapy attempts to deliver systemic radiation selectively to cancer cells...